199 related articles for article (PubMed ID: 35730194)
1. Low Tumor Infiltrating Mast Cell Density Reveals Prognostic Benefit in Cervical Carcinoma.
Guo F; Kong WN; Li DW; Zhao G; Wu HL; Anwar M; Shang XQ; Sun QN; Ma CL; Ma XM
Technol Cancer Res Treat; 2022; 21():15330338221106530. PubMed ID: 35730194
[No Abstract] [Full Text] [Related]
2. Low tumor infiltrating mast cell density confers prognostic benefit and reflects immunoactivation in colorectal cancer.
Mao Y; Feng Q; Zheng P; Yang L; Zhu D; Chang W; Ji M; He G; Xu J
Int J Cancer; 2018 Nov; 143(9):2271-2280. PubMed ID: 29873076
[TBL] [Abstract][Full Text] [Related]
3. Mining of immunological and prognostic-related biomarker for cervical cancer based on immune cell signatures.
Wang N; Nanding A; Jia X; Wang Y; Yang C; Fan J; Dong A; Zheng G; Ma J; Shi X; Yang Y
Front Immunol; 2022; 13():993118. PubMed ID: 36341424
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
[TBL] [Abstract][Full Text] [Related]
5. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S
BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197
[TBL] [Abstract][Full Text] [Related]
7. Construction and validation of a metabolic gene-associated prognostic model for cervical carcinoma and the role on tumor microenvironment and immunity.
Huang J; Luo F; Shi M; Luo J; Ma C; Li S; Wei Y; Guo R; Li T
Aging (Albany NY); 2021 Dec; 13(23):25072-25088. PubMed ID: 34852326
[TBL] [Abstract][Full Text] [Related]
8. Mast cell marker gene signature in head and neck squamous cell carcinoma.
Cai Z; Tang B; Chen L; Lei W
BMC Cancer; 2022 May; 22(1):577. PubMed ID: 35610596
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognosis-related genes in the cervical cancer immune microenvironment.
Yang L; Yang Y; Meng M; Wang W; He S; Zhao Y; Gao H; Tang W; Liu S; Lin Z; Li L; Hou Z
Gene; 2021 Jan; 766():145119. PubMed ID: 32946928
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures.
Peng L; Hayatullah G; Zhou H; Chang S; Liu L; Qiu H; Duan X; Han L
PLoS One; 2021; 16(4):e0249374. PubMed ID: 33901225
[TBL] [Abstract][Full Text] [Related]
11. Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data.
Tian X; Xu W; Wang Y; Anwaier A; Wang H; Wan F; Zhu Y; Cao D; Shi G; Zhu Y; Qu Y; Zhang H; Ye D
Oncoimmunology; 2020 Jun; 9(1):1784529. PubMed ID: 32923148
[TBL] [Abstract][Full Text] [Related]
12. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
[TBL] [Abstract][Full Text] [Related]
13. CD48 suppresses proliferation and migration as an immune-related prognostic signature in the cervical cancer immune microenvironment.
Ma Y; Yang Z; Liu J; Wang D
Carcinogenesis; 2024 Feb; 45(1-2):57-68. PubMed ID: 37279525
[TBL] [Abstract][Full Text] [Related]
14. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
15. [The Expression of RTN1 in Lung Adenocarcinoma and
Its Effect on Immune Microenvironment].
Zhu S; Zu L; Xu S
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
[TBL] [Abstract][Full Text] [Related]
17. SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma.
Jiang P; Cao Y; Gao F; Sun W; Liu J; Ma Z; Xie M; Fu S
BMC Cancer; 2021 Jun; 21(1):694. PubMed ID: 34116656
[TBL] [Abstract][Full Text] [Related]
18. Identification of key biomarkers and related immune cell infiltration in cervical cancer tissue based on bioinformatics analysis.
Zhu G; Xiong Z; Chen W; Zhu Z; Wang W
Sci Rep; 2023 Jun; 13(1):10121. PubMed ID: 37344577
[TBL] [Abstract][Full Text] [Related]
19. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer immune infiltration microenvironment identification, construction of immune scores, assisting patient prognosis and immunotherapy.
Yao S; Zhao L; Chen S; Wang H; Gao Y; Shao NY; Dai M; Cai H
Front Immunol; 2023; 14():1135657. PubMed ID: 36969161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
